Comparative Review of Medical Supply Chain Failure Patterns and Institutional Response Mechanisms During Global Health Emergencies
Abstract
Global health emergencies repeatedly expose systemic weaknesses in medical supply chains, resulting in critical shortages of essential medicines, personal protective equipment, diagnostics, and life-saving devices. Events such as the COVID-19 pandemic, Ebola outbreaks, and influenza pandemics revealed how structural fragility, governance gaps, and coordination failures amplify supply disruptions and undermine emergency response capacity. This review provides a comparative analysis of medical supply chain failure patterns observed across major global health crises, with particular emphasis on procurement bottlenecks, manufacturing concentration risks, logistics disruptions, information asymmetries, and regulatory delays. In parallel, the paper critically examines institutional response mechanisms adopted by governments, multilateral organizations, healthcare providers, and private sector actors to mitigate these failures. Using a structured review methodology, the study synthesizes evidence from peer-reviewed literature, policy reports, and post-crisis assessments to identify recurring failure typologies and evaluate the effectiveness of institutional interventions such as emergency stockpiling, centralized procurement, regulatory flexibilities, digital supply chain platforms, and public–private partnerships. Comparative insights highlight how variations in governance capacity, health system maturity, and international coordination influence resilience outcomes. The review further discusses the role of data transparency, predictive analytics, and supply chain diversification in strengthening preparedness for future emergencies. By integrating supply chain theory with institutional response analysis, this paper contributes a consolidated framework for understanding vulnerability–response dynamics in medical supply systems. The findings aim to inform policymakers, healthcare administrators, and global health stakeholders seeking to design more resilient, adaptive, and equitable medical supply chains capable of withstanding future global health shocks.